Edition:
United Kingdom

Onconova Therapeutics Inc (ONTX.OQ)

ONTX.OQ on NASDAQ Stock Exchange Capital Market

1.38USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$1.38
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
30,319
52-wk High
$3.88
52-wk Low
$1.21

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.11 -0.707
Jun '17 0.32 -0.287
Mar '17 0.21 -1.232
FY 2016 Dec '16 0.17 -0.804
Sep '16 1.65 -0.294
Jun '16 2.25 -1.964
Mar '16 1.47 -2.650
FY 2015 Dec '15 9.60 1.279
Sep '15 1.62 -0.003
Jun '15 0.12 -4.125
Mar '15 0.11 -5.687
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 3 0.23 0.50 0.00 --
Year Ending Dec-17 3 0.86 1.10 0.64 0.00
Year Ending Dec-18 4 3.09 6.50 0.00 0.00
Earnings (per share)
Quarter Ending Dec-17 3 -0.70 -0.66 -0.72 -0.78
Year Ending Dec-17 3 -2.84 -2.75 -2.94 -3.30
Year Ending Dec-18 4 -2.07 -1.67 -2.59 -1.93
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.14 32.93
P/E High - Last 5 Yrs. -- 40.91 45.62
P/E Low - Last 5 Yrs. -- 23.80 24.34
Beta 0.14 0.90 0.88
Price to Sales (TTM) 7.31 3.93 5.40
Price to Book (MRQ) -- 4.81 5.38
Price to Tangible Book (MRQ) -- 5.53 6.78
Price to Cash Flow (TTM) -- 23.04 23.45
% Owned Institutions 26.87 0.88 1.40

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.52
Dividend 5 Year Growth Rate -- 4.33 5.17
Payout Ratio(TTM) -- 45.73 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -85.59 3.57 9.00
Sales (TTM) vs TTM 1 Yr. Ago -84.22 4.66 5.38
Sales - 5 Yr. Growth Rate 30.12 10.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 85.38 16.54 19.67
EPS (TTM) vs TTM 1 Yr. Ago 21.60 -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.79
Capital Spending - 5 Yr. Growth Rate -- 15.30 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) 1.62 2.88 2.98
LT Debt to Equity (MRQ) -- 9.47 11.56
Total Debt to Equity (MRQ) -- 13.43 15.81
Interest Coverage (TTM) -- 36.29 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.14 54.83
Gross Margin - 5 Yr. Avg. -- 52.29 52.40
EBITD Margin (TTM) -998.77 -- --
EBITD - 5 Yr. Avg -282.89 18.46 15.24
Operating Margin (TTM) -1,002.80 14.50 7.76
Operating Margin - 5 Yr. Avg. -285.00 14.42 10.75
Pre-Tax Margin (TTM) -761.54 14.95 8.57
Pre-Tax Margin - 5 Yr. Avg. -290.16 14.74 11.17
Net Profit Margin (TTM) -762.13 11.22 4.88
Net Profit Margin - 5 Yr. Avg. -290.86 11.08 7.47
Effective Tax Rate (TTM) -- 23.21 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.44 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 102,522 953,213,828 864,680,848
Net Income/Employee (TTM) -781,348 112,151,383 101,718,394
Receivable Turnover (TTM) 1.98 5.60 5.76
Inventory Turnover (TTM) -- 2.58 3.34
Asset Turnover (TTM) 0.15 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -111.27 11.42 11.00
Return on Assets - 5 Yr. Avg. -73.07 13.00 12.43
Return on Investment (TTM) -307.64 14.86 14.46
Return on Investment - 5 Yr. Avg. -96.91 17.00 16.28
Return on Equity (TTM) -4,335.58 16.28 16.05
Return on Equity - 5 Yr. Avg. -- 18.03 17.51
  1 Year 3 Year 5 Year
Sales % -51.59 5.28 30.12
EPS (TTM) % 57.87 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Onconova Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 25.49%
# of Holders: 18
Total Shares Held: 2,745,927
3 Mo. Net Change: 95,631
# New Positions: 3
# Closed Positions: 5
# Increased Positions: 8
# Reduced Positions: 8
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.